Literature DB >> 19533809

Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites.

Kenneth J Vega1, Sian Chisholm, M Mazen Jamal.   

Abstract

AIM: To determine the effect of ethnicity on the severity of reflux esophagitis (RE) and its complications.
METHODS: A retrospective search of the endoscopy database at the University of Florida Health Science Center/Jacksonville for all cases of reflux esophagitis and its complications from January 1 to March 31, 2001 was performed. Inclusion criteria were endoscopic evidence of esophagitis using the LA classification, reflux related complications and self-reported ethnicity. The data obtained included esophagitis grade, presence of a hiatal hernia, esophageal ulcer, stricture and Barrett's esophagus, and endoscopy indication.
RESULTS: The search identified 259 patients with RE or its complications, of which 171 were non-Hispanic whites and 88 were African Americans. The mean ages and male/female ratios were similar in the two groups. RE grade, esophageal ulcer, stricture and hiatal hernia frequency were likewise similar in the groups. Barrett's esophagus was present more often in non-Hispanic whites than in African Americans (15.8% vs 4.5%; P < 0.01). Heartburn was a more frequent indication for endoscopy in non-Hispanic whites with erosive esophagitis than in African Americans (28.1% vs 7.9%; P < 0.001).
CONCLUSION: Distribution of RE grade and frequency of reflux-related esophageal ulcer, stricture and hiatal hernia are similar in non-Hispanic whites and African Americans. Heartburn was more frequently and nausea/vomiting less frequently reported as the primary endoscopic indication in non-Hispanic whites compared with African Americans with erosive esophagitis or its complications. African Americans have a decreased prevalence of Barrett's esophagus compared with non-Hispanic whites.

Entities:  

Mesh:

Year:  2009        PMID: 19533809      PMCID: PMC2699005          DOI: 10.3748/wjg.15.2878

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Opposing time trends of peptic ulcer and reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

2.  Body-mass index and symptoms of gastroesophageal reflux in women.

Authors:  Brian C Jacobson; Samuel C Somers; Charles S Fuchs; Ciarán P Kelly; Carlos A Camargo
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

3.  Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

Authors:  J P Galmiche; P Barthelemy; B Hamelin
Journal:  Aliment Pharmacol Ther       Date:  1997-08       Impact factor: 8.171

Review 4.  The role of race/ethnicity in the epidemiology of esophageal cancer.

Authors:  L M Brown
Journal:  J Assoc Acad Minor Phys       Date:  2000

5.  Associations between different forms of gastro-oesophageal reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

6.  Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification.

Authors:  L R Lundell; J Dent; J R Bennett; A L Blum; D Armstrong; J P Galmiche; F Johnson; M Hongo; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

7.  Patient race/ethnicity and quality of patient-physician communication during medical visits.

Authors:  Rachel L Johnson; Debra Roter; Neil R Powe; Lisa A Cooper
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

8.  Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease.

Authors:  S J Spechler; S K Jain; D A Tendler; R A Parker
Journal:  Aliment Pharmacol Ther       Date:  2002-10       Impact factor: 8.171

9.  Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.

Authors:  T L Venables; R D Newland; A C Patel; J Hole; C Wilcock; M L Turbitt
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

10.  Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy.

Authors:  Julian A Abrams; Sydney Fields; Charles J Lightdale; Alfred I Neugut
Journal:  Clin Gastroenterol Hepatol       Date:  2007-12-11       Impact factor: 11.382

View more
  5 in total

1.  African Americans with Barrett's esophagus are less likely to have dysplasia at biopsy.

Authors:  Joe E Khoury; Sian Chisholm; M Mazen Jamal; Carlos Palacio; Sunitha Pudhota; Kenneth J Vega
Journal:  Dig Dis Sci       Date:  2011-09-11       Impact factor: 3.199

2.  Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus.

Authors:  Prashanthi N Thota; Shamiq Zackria; Madhusudhan R Sanaka; Deepa Patil; John Goldblum; Rocio Lopez; Amitabh Chak
Journal:  J Clin Gastroenterol       Date:  2017 May/Jun       Impact factor: 3.062

3.  Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi.

Authors:  Chun-Yan Niu; Yong-Li Zhou; Rong Yan; Ni-La Mu; Bao-Hua Gao; Fang-Xiong Wu; Jin-Yan Luo
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

4.  Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men.

Authors:  Jennifer R Kramer; Lori A Fischbach; Peter Richardson; Abeer Alsarraj; Stephanie Fitzgerald; Yasser Shaib; Neena S Abraham; Maria Velez; Rhonda Cole; Bhupinderjit Anand; Gordana Verstovsek; Massimo Rugge; Paola Parente; David Y Graham; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-12-04       Impact factor: 11.382

5.  African-Americans, Hispanic Americans, and non-Hispanic whites without GERD or reflux symptoms have equivalent 24-h pH esophageal acid exposure.

Authors:  Kenneth J Vega; Tracy Langford; Carlos Palacio; Janet Watts; M Mazen Jamal
Journal:  Dig Dis Sci       Date:  2013-09-14       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.